Epidermal barrier dysfunction, driven by disorganization and altered composition of the stratum corneum (SC) lipid matrix, underlies multiple inflammatory dermatoses, namely atopic dermatitis (AD). The lipid fraction derived from Black Soldier Fly larvae (BSFL) biomass has emerged as a promising biomaterial for skin health applications, particularly for restoring barrier function. Following previous work on the development of solid lipid nanoparticles (SLNs) incorporating BSFL lipid extract, the present study focused on the mechanistic evaluation of the occlusive, moisturizing and skin reinforcement potential of these nanoformulations (NFs), by exploring both in vitro and in vivo models. The compatibility assays showed no adverse effects after patch testing on healthy or atopic individuals, nor alterations on skin hydration, transepidermal water loss (TEWL), or redness. In vitro studies confirmed the ability of these NFs to form an occlusive lipid film, hampering moisture loss, with 39% reduction of water loss compared to the control. Efficacy assays in human volunteers revealed a statistically significant improvement in epidermal conditions at treated sites, evidenced by enhanced SC hydration. The plastic occlusion stress test (POST) revealed a trend toward a reduced evaporation half-life, suggesting a modulation of the epidermal water dynamics, although the effect did not reach statistical significance. Overall, BSFL-based lipid nanoparticles emerge as emollient agents with broad potential for incorporation into next-generation cosmetic and pharmaceutical products for the management of AD.
Almeida et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: